SearchDictionaryMobileLogin

Jonathan S T Sham Selected Research

Carcinoma (Carcinomatosis)

07/2008Phase II study of gefitinib for the treatment of recurrent and metastatic nasopharyngeal carcinoma.
10/2007Stereotactic radiosurgery versus gold grain implantation in salvaging local failures of nasopharyngeal carcinoma.
11/2006Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial.
09/2006Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma.
08/2006Preservation of quality of life after intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: results of a prospective longitudinal study.
08/2006Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: Subgroup analysis of two Phase III trials.
01/2006Co-overexpression of fibroblast growth factor 3 and epidermal growth factor receptor is correlated with the development of nonsmall cell lung carcinoma.
12/2005Re-irradiation of nasopharyngeal carcinoma with intensity-modulated radiotherapy.
10/2005Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group.
10/2005Induction chemotherapy with cisplatin and gemcitabine followed by reirradiation for locally recurrent nasopharyngeal carcinoma.
07/2005A phase II study of docetaxel and cisplatin as first-line chemotherapy in patients with metastatic nasopharyngeal carcinoma.
02/2005Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials.
01/2005Up-regulated expression of cytoplasmic clusterin in human ovarian carcinoma.
10/2004Quantitative analysis of plasma cell-free Epstein-Barr virus DNA in nasopharyngeal carcinoma after salvage nasopharyngectomy: a prospective study.
10/2004Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function.
07/2004Prognostic impact of hemoglobin levels on treatment outcome in patients with nasopharyngeal carcinoma treated with sequential chemoradiotherapy or radiotherapy alone.
07/2004Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study.
05/2004Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy.
02/2004A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5-fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma.
07/2003EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma.
06/2003A phase II study of capecitabine in patients with recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy.
10/2002Significance of scheduling on the cytotoxicity of radiation and cisplatin combination treatment in nasopharyngeal carcinoma cells.
04/2002Control of regional metastasis after induction chemotherapy and radiotherapy for nasopharyngeal carcinoma.

Articles by Research Topic

Disease

23Carcinoma (Carcinomatosis)
07/2008 - 04/2002
3Hepatocellular Carcinoma (Hepatoma)
07/2007 - 08/2002
3Neoplasm Metastasis (Metastasis)
07/2007 - 04/2002
2Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
04/2008 - 10/2005
2Neoplasms (Cancer)
07/2007 - 11/2005
1Xerostomia
11/2006
1Glioblastoma (Glioblastoma Multiforme)
11/2005
1Ovarian Neoplasms (Ovarian Cancer)
06/2004
1Liver Neoplasms (Liver Cancer)
01/2004

Drug/Important Bio-Agent (IBA)

5Cisplatin (Platino)FDA LinkGeneric
10/2005 - 10/2002
3Epidermal Growth Factor Receptor (EGF Receptor)IBA
01/2006 - 05/2004
2capecitabine (Xeloda)FDA Link
04/2008 - 06/2003
2Fibroblast Growth Factor 3IBA
07/2007 - 01/2006
2DNA (Deoxyribonucleic Acid)IBA
10/2004 - 07/2003
1gefitinib (Iressa)FDA Link
07/2008
1GoldIBA
10/2007
1Carbon MonoxideIBA
01/2006
1gemcitabineFDA Link
10/2005
1docetaxel (Taxotere)FDA Link
07/2005
1ClusterinIBA
01/2005
1Hemoglobins (Hemoglobin)IBA
07/2004
1eIF-5A2IBA
06/2004
1Fluorouracil (Carac)FDA LinkGeneric
02/2004
1IfosfamideFDA LinkGeneric
02/2004
1Leucovorin (Folinic Acid)FDA LinkGeneric
02/2004
1VimentinIBA
01/2004
1Interleukin-4 (Interleukin 4)IBA
01/2004
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2004
1PlatinumIBA
06/2003
1Hepatitis B Surface Antigens (HBsAg)IBA
08/2002

Therapy/Procedure

9Drug Therapy (Chemotherapy)
09/2006 - 04/2002
4Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
11/2006 - 10/2004
2Adjuvant Chemotherapy
07/2004 - 02/2004